Becton Dickinson & Co (MIL:1BDX)
€ 211.5 -2.1 (-0.98%) Market Cap: 60.75 Bil Enterprise Value: 77.74 Bil PE Ratio: 37.37 PB Ratio: 2.48 GF Score: 64/100

Becton Dickinson and Co at Cowen Health Care Conference (Virtual) Transcript

Mar 07, 2022 / 02:50PM GMT
Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good morning. I'm Josh Jennings from the Cowen Medical Devices team, and we're continuing down our med devices track at the 42nd Annual Cowen Healthcare Conference. We are thrilled to have David Hickey, the Executive Vice President of Becton, Dickinson and President of the Life Sciences segment joining us here this morning to give us some access and some time to dig into his business unit and learn a little bit more about the IDS and Biosciences franchises.

David, good morning, and thanks so much for joining us today.

David Hickey
Becton, Dickinson and Company - Executive VP & President of Life Sciences Segment

Joshua, pleasure to be here. Thank you for having me. Looking forward to the discussion.

Questions & Answers

Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Excellent. So we learned a lot at the Investor Day and then your team did

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot